Generally, TB affect the kidney & urologic system through mycobacterial seeding of the urogenital tract via heamatogenous spread
Renal & urologic tuberculosis (T.B.)
Generally, TB
affect the kidney & urologic system through mycobacterial
seeding of the urogenital tract via heamatogenous
spread that can be observed with pulmonary
infection or with reactivation or miliary
spreading. Less common, renal parenchyma can be involved via interstitial nephritis & or via glomerulonephritis (GN).
TB bacilli can invade
the medullary interstitium leading to granuloma
formation that may heal with fibrous tissues formation (with no overt clinical renal disease) or, many years later on, they
can break down & rupture into tubular lumen with
excreting TB bacilli into the UT >> continuous TB spreading. However, descended spread of
infection along the ureter & bladder may induce ureteric stricture,
obstructive uropathy, hydronephrosis, & kidney dysfunction. At
the begining, renal & urologic TB
are symptomless; but pyuria and/or microscopic
hematuria can be seen incidentally. Once the pathology has proceeded
to involve the UB, Sms of frequency, dysuria,
urgency, as well as nocturia
can be seen in about 50%
of ptns; hematuria with low back pain may develop in one 1/3rd of ptns. Systemic manifestations (fever, weight loss) are not common. With TB advanced disease ESRD may develop and, in
rare cases, a refractory HT.
Characteristically
lab findings may include persistent pyuria (sterile pyuria)
+ acidic urine
with urine culture is persistently negative. Painless
macroscopic or microscopic
hematuria is persistent in > 90 % of ptns. SCr is often normal with unilateral
renal involvement. Increased SCr, however, may be seen with the presence of bilateral renal
involvement and/or with interstitial
nephritis or GN.
Dgx of renal and/or
urologic TB
should be expected in ptns with relevant clinical criteria (urine frequency, dysuria, hematuria, and/or pyuria) with
relevant epidemiologic environment (previous
TB infection/disease, possible TB exposure, and/or past/present resident or
travelling to an endemic zones). Dgx of urogenital TB may be established by identification of
tubercle bacilli
in urine. 3-6 early-morning
urine sampling should be examined for urine mycobacterial
culture or urine
PCR for M. TB. Radiological
examination is also required for suspected renal/urologic TB. CT with
contrast is preferable if available; in addition to high-resolution US
& IVP. Generally, radiological testing
concomitant upper + lower
UT affection
is a robust suggestion of TB. Multiple strictures
along the collecting system (fr: kidney
pelvis to uretero-vesical junction) can be seen in 60-84 % of ptns.
Genital tuberculosis
Male genital tract: TB can
affect the prostate, seminal vesicle, vas
deferens, epididymis, testicle,
Cooper gland, as well as the penis. Epididymitis is the most commonly involved among males with genital TB; it is affected in 10-55 % ptns. Clinical findings include
scrotal nodule or epididymal hardening
in 50% of ptns,
usually bilateral in 34
% of ptns. Female genital tract: TB infection can affect the fallopian tubes, endometrium, as well as the ovaries but generally sparing the myometrium. Fallopian tubes are involved in 90-100
% of ptns, usually with bilateral affection. Women genital TB is observed clinically
as infertility (40-76 %), pelvic/abdominal
pain or mass (50
%), as well as menstrual disturbances (25
%).
Dgx of genital TB should be expected with relevant clinical criteria (men: nodular scrotal lesions, prostatic and/or
testicular and/or non-healing ulceration
of the external genitalia; in ladies:
infertility, pelvic/abdominal pain, and/or menstrual disturbances) as well as relevant environmental
factors (previous TB, exposure, and/or residents/traveling to zones with
endemic TB).
Dgx of male genital TB starts with assessing
the UT. With absent evidence for
urinary involvement, men with suspected genital TB proceed to biopsy of the affected site;
biopsy specimen should be sent for histopathology
testing, staining with acid-fast
bacilli, & mycobacterial culture.
In women with suspected genital TB,
hysterosalpingo-gram may declare fallopian tube obstruction/constriction
and/or uterine adhesions or deformities.
Histopathological Dgx may be made via endometrial or fallopian tube
biopsy for histology + C&S,
or via mycobacterial culture of menstrual fluid.
Samples should be sent for histopathologic testing, acid-fast
bacilli staining, & mycobacterial
culture.
Management
Ptns with urogenital TB
should be ttt with anti-T.B.
therapy; generally, therapeutic approach is similar to that of pulmonary TB. Ptns
with ureteric
stricture & hydro nephrotic changes, an early stent placement or percutaneous nephrostomy is beneficial with obstructive
uropathy and potentially reversible if provided early.
COMMENTS